Growth Metrics

Bio-Techne (TECH) Net Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 89.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -13.44%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 33.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -29.82%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 32.17%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 43.58%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.58%
Dec 31, 2025 76.23%
Sep 30, 2025 -76.42%
Jun 30, 2025 -23.78%
Mar 31, 2025 8.63%
Dec 31, 2024 -33.20%
Sep 30, 2024 165.87%
Jun 30, 2024 -19.85%
Mar 31, 2024 -15.03%
Dec 31, 2023 -32.61%
Sep 30, 2023 -44.42%
Jun 30, 2023 93.38%
Mar 31, 2023 -40.58%
Dec 31, 2022 -47.12%
Sep 30, 2022 57.01%
Jun 30, 2022 47.56%
Mar 31, 2022 -99.61%
Dec 31, 2021 51.89%
Sep 30, 2021 27.29%
Jun 30, 2021 -31.58%
Mar 31, 2021 36.28%
Dec 31, 2020 -29.95%
Sep 30, 2020 47.81%
Jun 30, 2020 -33.00%
Mar 31, 2020 366.12%
Dec 31, 2019 39.92%
Sep 30, 2019 28.85%
Jun 30, 2019 101.96%
Mar 31, 2019 29.66%
Dec 31, 2018 -34.01%
Sep 30, 2018 -31.61%
Jun 30, 2018 39.92%
Mar 31, 2018 -61.84%
Dec 31, 2017 203.71%
Sep 30, 2017 55.83%
Jun 30, 2017 -46.59%
Mar 31, 2017 -72.76%
Dec 31, 2016 -38.68%
Sep 30, 2016 26.13%
Jun 30, 2016 -61.96%
Mar 31, 2016 -29.80%
Dec 31, 2015 19.32%
Sep 30, 2015 -42.77%
Jun 30, 2015 -63.99%
Mar 31, 2015 7.43%
Dec 31, 2014 -41.83%
Sep 30, 2014 -350.18%
Jun 30, 2014 63.18%
Mar 31, 2014 8.10%
Dec 31, 2013 -15.04%
Sep 30, 2013 -88.82%
Jun 30, 2013 44.70%
Mar 31, 2013 28.75%
Dec 31, 2012 -15.37%
Sep 30, 2012 -8.73%